6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway

Excessive synthesis of triglycerides and cholesterol accelerates the progression of hepatic steatosis in metabolic-associated fatty liver disease (MAFLD). However, the precise mechanism by which 6-gingerol mitigates hepatic steatosis in MAFLD model mice has yet to be fully understood. The present st...

Full description

Bibliographic Details
Main Authors: Qingsong Xia, Fuer Lu, Yu Chen, Jingbin Li, Zhaoyi Huang, Ke Fang, Meilin Hu, Yujin Guo, Hui Dong, Lijun Xu, Jing Gong
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223018589
_version_ 1797364247866376192
author Qingsong Xia
Fuer Lu
Yu Chen
Jingbin Li
Zhaoyi Huang
Ke Fang
Meilin Hu
Yujin Guo
Hui Dong
Lijun Xu
Jing Gong
author_facet Qingsong Xia
Fuer Lu
Yu Chen
Jingbin Li
Zhaoyi Huang
Ke Fang
Meilin Hu
Yujin Guo
Hui Dong
Lijun Xu
Jing Gong
author_sort Qingsong Xia
collection DOAJ
description Excessive synthesis of triglycerides and cholesterol accelerates the progression of hepatic steatosis in metabolic-associated fatty liver disease (MAFLD). However, the precise mechanism by which 6-gingerol mitigates hepatic steatosis in MAFLD model mice has yet to be fully understood. The present study observed that 6-gingerol administration exhibited significant protective effects against obesity, insulin resistance, and hepatic steatosis in mice subjected to a high-fat diet (HFD), and mitigated lipid accumulation in HepG2 cells treated with palmitate (PA). Following the hepatic lipidomic analysis, we confirmed that the AMPK-SREBPs signaling pathway as the underlying molecular mechanism by which 6-gingerol inhibited triglyceride and cholesterol biosynthesis, both in vivo and in vitro, through Western blot and immunofluorescence assay. Additionally, the application of an AMPK agonist/inhibitor further validated that 6-gingerol promoted AMPK activation by increasing the phosphorylation level of AMPK in vitro. Notably, the inhibitory effect of 6-gingerol on cholesterol biosynthesis, rather than triglyceride biosynthesis, was significantly diminished after silencing SREBP2 using a lentiviral plasmid shRNA in HepG2 cells. Our study demonstrates that 6-gingerol mitigates hepatic triglyceride and cholesterol biosynthesis to alleviate hepatic steatosis by activating the AMPK-SREBPs signaling pathway, indicating that 6-gingerol may be a potential candidate in the therapy of MAFLD.
first_indexed 2024-03-08T16:33:33Z
format Article
id doaj.art-b387effc22304be49c6b34a4a5639989
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-03-08T16:33:33Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-b387effc22304be49c6b34a4a56399892024-01-06T04:38:07ZengElsevierBiomedicine & Pharmacotherapy0753-33222024-01-011701160606-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathwayQingsong Xia0Fuer Lu1Yu Chen2Jingbin Li3Zhaoyi Huang4Ke Fang5Meilin Hu6Yujin Guo7Hui Dong8Lijun Xu9Jing Gong10Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China; Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, ChinaDepartment of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, ChinaInstitute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, ChinaInstitute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, ChinaInstitute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China; Correspondence to: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.Excessive synthesis of triglycerides and cholesterol accelerates the progression of hepatic steatosis in metabolic-associated fatty liver disease (MAFLD). However, the precise mechanism by which 6-gingerol mitigates hepatic steatosis in MAFLD model mice has yet to be fully understood. The present study observed that 6-gingerol administration exhibited significant protective effects against obesity, insulin resistance, and hepatic steatosis in mice subjected to a high-fat diet (HFD), and mitigated lipid accumulation in HepG2 cells treated with palmitate (PA). Following the hepatic lipidomic analysis, we confirmed that the AMPK-SREBPs signaling pathway as the underlying molecular mechanism by which 6-gingerol inhibited triglyceride and cholesterol biosynthesis, both in vivo and in vitro, through Western blot and immunofluorescence assay. Additionally, the application of an AMPK agonist/inhibitor further validated that 6-gingerol promoted AMPK activation by increasing the phosphorylation level of AMPK in vitro. Notably, the inhibitory effect of 6-gingerol on cholesterol biosynthesis, rather than triglyceride biosynthesis, was significantly diminished after silencing SREBP2 using a lentiviral plasmid shRNA in HepG2 cells. Our study demonstrates that 6-gingerol mitigates hepatic triglyceride and cholesterol biosynthesis to alleviate hepatic steatosis by activating the AMPK-SREBPs signaling pathway, indicating that 6-gingerol may be a potential candidate in the therapy of MAFLD.http://www.sciencedirect.com/science/article/pii/S07533322230185896-GingerolMAFLDTriglyceride biosynthesisCholesterol biosynthesisSREBPs
spellingShingle Qingsong Xia
Fuer Lu
Yu Chen
Jingbin Li
Zhaoyi Huang
Ke Fang
Meilin Hu
Yujin Guo
Hui Dong
Lijun Xu
Jing Gong
6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway
Biomedicine & Pharmacotherapy
6-Gingerol
MAFLD
Triglyceride biosynthesis
Cholesterol biosynthesis
SREBPs
title 6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway
title_full 6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway
title_fullStr 6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway
title_full_unstemmed 6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway
title_short 6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway
title_sort 6 gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in mafld by activating the ampk srebps signaling pathway
topic 6-Gingerol
MAFLD
Triglyceride biosynthesis
Cholesterol biosynthesis
SREBPs
url http://www.sciencedirect.com/science/article/pii/S0753332223018589
work_keys_str_mv AT qingsongxia 6gingerolregulatestriglycerideandcholesterolbiosynthesistoimprovehepaticsteatosisinmafldbyactivatingtheampksrebpssignalingpathway
AT fuerlu 6gingerolregulatestriglycerideandcholesterolbiosynthesistoimprovehepaticsteatosisinmafldbyactivatingtheampksrebpssignalingpathway
AT yuchen 6gingerolregulatestriglycerideandcholesterolbiosynthesistoimprovehepaticsteatosisinmafldbyactivatingtheampksrebpssignalingpathway
AT jingbinli 6gingerolregulatestriglycerideandcholesterolbiosynthesistoimprovehepaticsteatosisinmafldbyactivatingtheampksrebpssignalingpathway
AT zhaoyihuang 6gingerolregulatestriglycerideandcholesterolbiosynthesistoimprovehepaticsteatosisinmafldbyactivatingtheampksrebpssignalingpathway
AT kefang 6gingerolregulatestriglycerideandcholesterolbiosynthesistoimprovehepaticsteatosisinmafldbyactivatingtheampksrebpssignalingpathway
AT meilinhu 6gingerolregulatestriglycerideandcholesterolbiosynthesistoimprovehepaticsteatosisinmafldbyactivatingtheampksrebpssignalingpathway
AT yujinguo 6gingerolregulatestriglycerideandcholesterolbiosynthesistoimprovehepaticsteatosisinmafldbyactivatingtheampksrebpssignalingpathway
AT huidong 6gingerolregulatestriglycerideandcholesterolbiosynthesistoimprovehepaticsteatosisinmafldbyactivatingtheampksrebpssignalingpathway
AT lijunxu 6gingerolregulatestriglycerideandcholesterolbiosynthesistoimprovehepaticsteatosisinmafldbyactivatingtheampksrebpssignalingpathway
AT jinggong 6gingerolregulatestriglycerideandcholesterolbiosynthesistoimprovehepaticsteatosisinmafldbyactivatingtheampksrebpssignalingpathway